- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-resistant Prostate Cancer in Finland
Total 340 results
-
Tampere UniversityLund University; University of Helsinki; Hospital District of Helsinki and Uusimaa and other collaboratorsEnrolling by invitation
-
Life Molecular Imaging SATerminatedProstate CancerAustria, Finland
-
Lidds ABUppsala UniversityCompletedProstate CancerFinland, Sweden
-
Turku University HospitalRecruiting
-
Kuopio University HospitalUnknownProstate CancerFinland
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
Turku University HospitalMemorial Sloan Kettering Cancer Center; Tampere University Hospital; Mount Sinai... and other collaboratorsRecruitingProstate CancerFinland
-
Helsinki University Central HospitalActive, not recruitingProstate CancerFinland
-
Turku University HospitalCompleted
-
Tampere University HospitalVaralan urheiluopistoUnknown
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, France, Germany
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Turku University HospitalUnknown
-
Camurus ABCompletedPhase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate CancerProstate CancerFinland, Hungary
-
Turku University HospitalRecruitingProstatic Hyperplasia | Prostate CancerFinland
-
National Human Genome Research Institute (NHGRI)Completed
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Orion Corporation, Orion PharmaCompletedProstate CancerFinland, France, United Kingdom, Latvia
-
Hoffmann-La RocheCompletedMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaboratorsCompletedProstate Cancer | Metastatic CancerUnited States, Canada
-
Life Molecular Imaging SACompleted
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Janssen Research & Development, LLCCompletedMetastatic Prostate CancerUnited States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Scandinavian Prostate Cancer GroupUnknownProstate CancerFinland, Denmark, Iceland, Norway, Sweden
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPain | Breast Cancer | Prostate Cancer | Metastatic CancerUnited States, Canada
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Roger Williams Medical CenterSuspendedMetastatic CancersUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
Brown UniversityTerminated
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
GlaxoSmithKlineCompletedNeoplasms, Prostate | Prostate Cancer After a Radical TreatmentSpain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Brown UniversityKeitner/Family Therapy Research GrantCompletedBreast Cancer | Sexual Dysfunction | Prostate CancerUnited States
-
Lidds ABCMX ResearchCompletedProstate CancerCanada, Finland, Lithuania
-
Helsinki University Central HospitalKarolinska InstitutetRecruitingKidney Cancer | Urothelial Carcinoma | Prostate Carcinoma | Penile Cancer | Testicular CancerFinland
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland